by John McMillan | Aug 23, 2024 | Health
Justin Stebbing, Anglia Ruskin University Consuming too much caffeine is definitely bad for your health, and there may be good reasons why some people want to quit it altogether. But if you despair at the idea of giving up your morning coffee, fear not. There’s lots...
by John McMillan | Aug 23, 2024 | COVID-19, Immune Response, Inflammation, STORM
Dr. Philip McMillan, John McMillan The concept of a COVID-19 “STORM” (Spike-Triggered Autoimmune Response Mechanism) is emerging as a potential concern in the ongoing pandemic. This theory, proposed by Dr. Philip McMillan, suggests that circulating...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Nasia Safdar, University of Wisconsin-Madison A new study from the National Institutes of Health shows a jump in both hospital-acquired infections and resistance to the antibiotics used to treat them. The findings are based on data gathered at 120 U.S. hospitals from...
by John McMillan | Aug 16, 2024 | COVID-19, Medical Research
Ziyad Al-Aly, Washington University in St. Louis Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
Recent Comments